Confident Investing Starts With TipRanks Premium

Get 55% Off
TipRanks
Go Ultimate55% OFF

OrganoClick AB (0CF) Stock Price & Analysis

0CF Stock Chart & Stats

€0.03-€0.00(-6.06%)
At close: 5:30 PM GMT+1
EUR 0.1EUR 0.2EUR 0.315 Aug4 Apr1 Sep4 Feb24 Apr27 Oct
Day’s Range
EUR 0.03 - EUR 0.03
52-Week Range
EUR 0.01 - EUR 0.19
Previous Close
EUR 0.03
Volume
0
Average Volume (3M)
45
Market Cap
EUR 7.62M
Enterprise Value
EUR 130.45M
Total Cash (Recent Filing)
EUR 480.00K
Total Debt (Recent Filing)
EUR 78.56M
Price to Earnings (P/E)
―
Beta
3.20
Next Earnings
Nov 05, 2026 (Est.)
EPS Estimate
N/A
Next Dividend Ex-Date
N/A
Dividend Yield
N/A

Bulls Say, Bears Say

Bulls Say

Proprietary Green-chemistry Platform

The proprietary bio-based technology platform targets replacement of fossil-based and hazardous substances across wood, textiles, and fiber materials. This creates potential for repeatable applications across multiple end markets and supports a differentiated business model beyond a single product.

Losses Improved From 2022

Improvement in losses from the very weak 2022 level indicates some progress in financial performance, even though profitability remains negative. If this improvement continues, it could provide a foundation for eventual operating leverage and a more sustainable earnings profile.

Moderating Cash Burn

The reduction in free-cash outflow versus 2025 suggests that cash discipline or operating performance has improved at the margin. Continued moderation would extend financial runway and reduce the pace at which the company must rely on external funding while pursuing growth.

Bears Say

Declining Revenue And Deep Losses

Revenue contraction combined with deeply negative operating and net margins shows that the current business scale is not yet translating into economic profitability. Persistent losses can restrict reinvestment, weaken resilience, and make a durable recovery dependent on a meaningful improvement in demand or margins.

Very High Leverage And Eroded Equity

Debt materially exceeds the company’s small equity base, leaving limited balance-sheet flexibility as losses continue. This capital structure raises refinancing and potential dilution risk, while interest and repayment obligations can constrain investment in the technology platform and commercial expansion.

Negative Operating And Free Cash Flow

The company continues to consume cash rather than funding operations internally, with both operating and free cash flow negative. This weakens self-financing capacity and increases dependence on financing while leverage is already elevated, making sustained cash-flow improvement important to long-term stability.

OrganoClick AB News

0CF FAQ

What was OrganoClick AB’s price range in the past 12 months?
OrganoClick AB lowest stock price was €0.01 and its highest was €0.19 in the past 12 months.
What is OrganoClick AB’s market cap?
OrganoClick AB’s market cap is €7.62M.
When is OrganoClick AB’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were OrganoClick AB’s earnings last quarter?
OrganoClick AB released its earnings results on Aug 12, 2026. The company reported -€0.003 earnings per share for the quarter.
Is OrganoClick AB overvalued?
Not enough analysts have published a price target to calculate whether the price is overvalued.
Does OrganoClick AB pay dividends?
OrganoClick AB does not currently pay dividends.
What is OrganoClick AB’s EPS estimate?
OrganoClick AB’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does OrganoClick AB have?
OrganoClick AB has 183,219,120 shares outstanding.
What happened to OrganoClick AB’s price movement after its last earnings report?
OrganoClick AB reported an EPS of -€0.003 in its last earnings report. Following the earnings report the stock price went up 17.857%.
Which hedge fund is a major shareholder of OrganoClick AB?
Currently, no hedge funds are holding shares in DE:0CF
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology